ADK Combo (Vitamins A, D3 & K2): The Fat-Soluble Bone & Cardiovascular Stack — A Research-Backed Guide
⚡ 60-Second Summary
ADK combo supplements package the three fat-soluble vitamins A, D3, and K2 together based on their synergistic roles in directing calcium to bone and away from arteries. Vitamin D3 drives calcium absorption; K2 (especially MK-7) activates the proteins (osteocalcin, matrix Gla-protein) that determine where that calcium goes; and vitamin A modulates how cells respond to vitamin D through shared receptor interactions.
Important caution: Preformed vitamin A (retinyl palmitate) has a Tolerable Upper Limit of 10,000 IU/day, and chronic intakes of 5,000+ IU/day have been associated with reduced bone density in some studies. Many ADK products contain 2,500–5,000 IU of preformed A. If you eat liver, take a multivitamin, or consume fortified foods, your total preformed A intake can approach or exceed the UL. Use beta-carotene as the vitamin A source if concerned — it cannot cause retinol toxicity.
Warfarin users: do not take K2 without consulting your anticoagulation provider.
What is an ADK combo supplement?
An ADK combo is a dietary supplement providing three fat-soluble vitamins together: vitamin A (usually as retinyl palmitate, sometimes partly as beta-carotene), vitamin D3 (cholecalciferol), and vitamin K2 (most commonly as MK-7, the long-chain menaquinone form with the most tissue activity). All three are fat-soluble — they require dietary fat for absorption and are stored in adipose tissue and the liver.
The combination is based on evidence that these vitamins work synergistically through overlapping receptor and protein systems:
- Vitamin D's nuclear receptor (VDR) forms obligate heterodimers with the retinoid X receptor (RXR), which is activated by retinoic acid (the active vitamin A metabolite). This means vitamin A status directly influences the transcriptional response to vitamin D.
- Vitamin K2 is required to carboxylate and activate Gla-proteins including osteocalcin (bone calcium binding) and matrix Gla-protein (MGP, arterial calcium inhibition) — proteins whose production is induced, in part, by vitamin D.
The theoretical framework is: vitamin D increases calcium absorption → K2 activates the proteins that direct calcium to bone → vitamin A ensures the VDR-RXR receptor system responds appropriately to vitamin D.
Evidence-based benefits of the ADK combination
1. Bone mineral density (D3 + K2, strong evidence; A additive)
The evidence for vitamin D3 and bone is extensive — adequate D3 status is required for normal calcium absorption and bone mineralization. Vitamin K2 (MK-7) adds to this by carboxylating osteocalcin, enabling it to bind calcium into the bone matrix. The 3-year Eindhoven trial (Knapen et al., 2013) demonstrated that 180 mcg/day of MK-7 significantly improved trabecular bone strength and reduced age-related BMD loss in postmenopausal women. The addition of retinol at appropriate doses may support VDR responsiveness, but direct RCT evidence for the triple combination on BMD is limited.
2. Cardiovascular calcification prevention (K2, strong individual evidence)
Arterial calcification — plaque hardening — is driven in part by insufficient matrix Gla-protein (MGP) carboxylation. Undercarboxylated MGP cannot inhibit calcium deposition in arterial walls. Vitamin K2 (MK-7 specifically, due to its longer half-life and superior tissue distribution vs K1) activates MGP and has been associated with reduced coronary artery calcification in observational studies. The Rotterdam Study (Geleijnse et al.) showed that dietary MK-7 intake (but not K1) was inversely associated with coronary heart disease mortality. The VitaK-CAC trial showed attenuation (but not reversal) of CAC progression with 180 mcg MK-7.
3. Immune function (vitamins A and D)
Both vitamin A and vitamin D are essential for normal innate and adaptive immunity. Vitamin D deficiency is associated with increased susceptibility to respiratory infections, and vitamin D supplementation modestly reduces acute respiratory infection risk (Martineau et al. 2017 meta-analysis). Vitamin A is essential for mucosal immune barriers and lymphocyte function. Combined adequacy is important for immune health, particularly in winter months and in deficiency-prevalent populations.
4. VDR-RXR receptor synergy (mechanistic, human evidence limited)
Vitamin D (as 1,25-dihydroxyvitamin D) binds VDR, which must form a heterodimer with RXR to bind DNA and regulate gene expression. RXR is activated by 9-cis-retinoic acid derived from vitamin A. In cell and animal studies, vitamin A status modulates VDR activity: adequate vitamin A enhances VDR signaling, while deficiency impairs it, and pharmacological retinol can compete with vitamin D for RXR binding. The clinical relevance in humans with normal dietary A intake is not precisely established — this remains primarily mechanistic support rather than trial-validated benefit of the combination.
Deficiency context for A, D, and K2
All three are commonly inadequate in Western populations:
- Vitamin D: ~40% of U.S. adults have serum 25(OH)D below 20 ng/mL (50 nmol/L — the deficiency cutoff). Higher rates in northern latitudes, people with darker skin, and older adults indoors.
- Vitamin K2: No established deficiency syndrome in adults (vitamin K1 maintains clotting), but undercarboxylated osteocalcin and MGP — markers of K2 insufficiency for extrahepatic functions — are common in populations eating Western (low-fermented food) diets.
- Vitamin A: Frank deficiency is rare in developed countries. But preformed retinol is concentrated in liver and dairy; people avoiding these may have suboptimal status. Overconsumption (from liver, high-dose supplements, or fortified foods) is the more common concern in Western populations.
Forms compared: A, D3, and K2 variants
| Vitamin | Preferred form in ADK | Alternative forms | Notes |
|---|---|---|---|
| Vitamin A | Retinyl palmitate (preformed, low-dose: 750–1,500 mcg RAE) | Beta-carotene (provitamin; no toxicity risk); mixed retinyl palmitate + beta-carotene | Preformed retinol has a UL of 3,000 mcg RAE; beta-carotene has no UL and cannot cause retinol toxicity. Safer to use beta-carotene if dietary retinol intake is already substantial. |
| Vitamin D3 | Cholecalciferol (D3) | Ergocalciferol (D2) — less potent at raising 25(OH)D | D3 raises serum 25(OH)D more effectively and has a longer half-life than D2. D3 is the preferred form. Common doses in ADK: 1,000–5,000 IU/day. |
| Vitamin K2 | MK-7 (menaquinone-7 — long half-life, high tissue distribution) | MK-4 (shorter half-life; must be dosed 3x/day for tissue effects); K1 (phylloquinone — mainly hepatic, poor extrahepatic distribution) | MK-7 at 90–180 mcg/day is the evidence-based dose for bone and cardiovascular Gla-protein carboxylation. MK-4 requires 45,000 mcg/day (used in Japanese pharmaceutical Menatetrenone) for bone effects at pharmacological doses. |
How much ADK should you take?
Doses vary substantially between products. Evidence-supported targets:
- Vitamin A (preformed retinol): 750–1,500 mcg RAE (2,500–5,000 IU) — check total intake from all sources; do not exceed 3,000 mcg RAE (10,000 IU) from all sources combined
- Vitamin D3: 1,000–4,000 IU/day for most adults without deficiency; 4,000–5,000 IU/day for those with confirmed deficiency (serum 25(OH)D <20 ng/mL) until repletion, then maintenance
- Vitamin K2 (MK-7): 90–180 mcg/day — the dose used in the major bone and cardiovascular trials; some practitioners use up to 360 mcg/day without documented harm
Take ADK with a fat-containing meal for optimal absorption of all three fat-soluble vitamins. Morning with breakfast (that includes some fat) is the most practical timing.
Safety and the vitamin A toxicity concern
Fat-soluble vitamins accumulate in the body and have a narrower therapeutic window than water-soluble vitamins.
Vitamin A (preformed retinol) — critical cautions
- Teratogenicity: Preformed vitamin A above 3,000 mcg RAE/day is teratogenic (causes birth defects). Pregnant women and those planning pregnancy should not exceed 770 mcg RAE/day from supplements, and should avoid high-dose retinol supplements entirely unless prescribed.
- Bone density paradox: While adequate vitamin A supports bone, observational studies (Michaelsson, Feskanich) suggest chronic intakes above ~1,500 mcg RAE/day may reduce BMD and increase hip fracture risk, possibly by promoting osteoclast activity or competing with vitamin D receptor binding.
- Liver toxicity: Chronic intakes well above the UL (years of 10,000+ IU/day preformed A) cause hepatotoxicity, hypervitaminosis A, and pseudotumor cerebri.
- Beta-carotene does NOT share these risks: Conversion from beta-carotene to retinol is downregulated when vitamin A status is adequate — no toxicity from food or supplement beta-carotene, though very high intakes cause benign carotenodermia (orange skin).
Vitamin D toxicity
Vitamin D toxicity (hypercalcemia) occurs with chronic supplemental intake above ~10,000 IU/day in healthy adults. At standard ADK doses (1,000–5,000 IU D3), this is not a concern for most people. Those with granulomatous diseases (sarcoidosis, tuberculosis) or primary hyperparathyroidism are exceptions — they can develop hypercalcemia at much lower doses.
Vitamin K2 safety
No UL has been established for vitamin K2. No toxicity has been documented at supplemental doses up to 360 mcg/day MK-7. The interaction with vitamin K antagonist anticoagulants (warfarin) is the most important safety consideration.
Drug and nutrient interactions
- Warfarin and other vitamin K antagonists: K2 (MK-7) will reduce anticoagulant efficacy and destabilize INR. Absolute contraindication to unsupervised K2 supplementation in patients on warfarin.
- Orlistat (weight loss drug): Blocks fat absorption and will significantly reduce absorption of all fat-soluble vitamins including A, D, and K2; monitor levels and supplement accordingly.
- Retinoids (isotretinoin, acitretin): Pharmacological retinoids plus supplemental preformed vitamin A = additive hypervitaminosis A risk; avoid preformed vitamin A supplements with retinoid therapy.
- Cholestyramine and bile acid sequestrants: Reduce absorption of fat-soluble vitamins.
- Calcium: ADK is often paired with calcium supplements; adequate K2 is important to ensure that supplemental calcium is directed to bone rather than soft tissue. But do not exceed total calcium UL (2,500 mg/day) from all sources.
- Magnesium: Required for vitamin D activation (25-hydroxylation and 1-hydroxylation both require magnesium-dependent enzymes); magnesium deficiency can blunt vitamin D response.
Check our free interaction checker for additional combinations.
Who might benefit (and who should be cautious)
| Most likely to benefit from ADK | Should exercise caution or avoid |
|---|---|
| Adults with confirmed low vitamin D (25(OH)D <20 ng/mL) taking D3 supplementation | Patients on warfarin or other vitamin K antagonists (K2 interaction) |
| Postmenopausal women supporting bone density alongside calcium and magnesium | Pregnant women (preformed vitamin A teratogenicity) |
| People with low dietary fermented food intake (low MK-7 dietary source) | People already consuming liver, cod liver oil, or high-dose multivitamins (retinol accumulation risk) |
| Individuals with coronary artery calcification seeking to slow progression | People with sarcoidosis, TB, or hyperparathyroidism (vitamin D hypercalcemia risk) |
Frequently asked questions
Why are A, D, and K2 combined in one supplement?
The three fat-soluble vitamins have interlinked roles in calcium metabolism. Vitamin D drives calcium absorption; K2 activates the proteins (osteocalcin, matrix Gla-protein) that direct calcium to bone and away from arteries; vitamin A modulates how cells respond to vitamin D through the VDR-RXR receptor heterodimer. The combination aims to optimize all three pathways simultaneously. Individual evidence for D3 and K2 is strong; the ADK-specific combination has moderate-level evidence.
Can I take ADK if I am already taking a multivitamin?
Check your multivitamin's vitamin A content. Most contain 750–1,500 mcg RAE of preformed retinol. Adding an ADK product with another 750–1,500 mcg RAE could approach or exceed the 3,000 mcg RAE UL, especially if you also eat liver or take cod liver oil. Either use an ADK product with beta-carotene (provitamin A, no toxicity risk) instead of preformed retinol, or choose a standalone D3+K2 product if your multi already covers vitamin A.
What is the best form of K2 — MK-4 or MK-7?
For supplementation, MK-7 is preferred because of its long half-life (72 hours vs 6–8 hours for MK-4), allowing once-daily dosing at 90–180 mcg with sustained tissue carboxylation. MK-4 at the doses typical in supplements (45–200 mcg) does not match the pharmacological Japanese trials that used 45,000 mcg (45 mg) of MK-4 three times daily for osteoporosis. For dietary sources, both forms are found in animal products (MK-4) and fermented foods like natto (MK-7).
Should pregnant women take ADK?
No — not without medical supervision. Preformed vitamin A (retinol/retinyl palmitate) is teratogenic above approximately 3,000 mcg RAE/day. Pregnant women are advised to get vitamin A primarily from food (dairy, eggs, orange and yellow vegetables) and prenatal vitamins carefully formulated for pregnancy. Standard prenatal vitamins contain safe doses. If a pregnant woman's clinician recommends vitamin D and K2 supplementation, a product without preformed vitamin A is safer.
Does taking more vitamin D require more K2?
This is a reasonable precautionary principle. High-dose vitamin D3 increases calcium absorption; without adequate K2, the risk of hypercalcemia and soft-tissue calcium deposition is theoretically higher. The established clinical doses are: for each 2,000–5,000 IU of D3, approximately 90–180 mcg of K2 (MK-7) is used in trials. This ratio is not rigidly established but is a reasonable framework. Magnesium (300–400 mg/day) is also important for vitamin D metabolism.
Related ingredients and articles
Vitamin D3
The most important fat-soluble vitamin for calcium, immunity, and bone — in depth.
Vitamin K2 (MK-7)
The menaquinone form of K2 with the best evidence for bone and arterial calcification.
Beta-Carotene
The safe provitamin A form — no retinol toxicity risk.
Magnesium
Essential cofactor for vitamin D activation — often needed alongside ADK.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.